N-(1,4-dihydro-5H-tetrazol-5-ylidene)-9-oxo-9H-xanthene-2-sulfonamide

Star1

DB04698ExperimentalSmall molecule

N-(1,4-dihydro-5H-tetrazol-5-ylidene)-9-oxo-9H-xanthene-2-sulfonamide: Overview.

Formula / weight: C₁₄H₉N₅O₄S · 343.317 g/mol (avg)
Also known as: 9-Oxo-N-(2H-tetrazol-5-yl)-9H-xanthene-2-sulfonamide

Resolves to

Compound

CAS353522-10-8ChEMBLCHEMBL202311PubChem6102777

Structure

InChIKeyHJWYZPGYPZNDTN-UHFFFAOYSA-NSMILES[H]N(C1=NN([H])N=N1)S(=O)(=O)C1=CC2=C(OC3=CC=CC=C3C2=O)C=C1

Targets

Q48255aroQ

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with N-(1,4-dihydro-5H-tetrazol-5-ylidene)-9-oxo-9H-xanthene-2-sulfonamide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account